MAD Study to Assess the Safety, Tolerability, PKs and Efficacy of YJ001 for Spray Use in Patients With DPNP

Abroad (travel likely)RecruitingPHASE1

Conditions

Diabetic Peripheral Neuropathic Pain

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Clinical Trials of Texas,LLC, Fredericksburg, Texas, United States
Contact: Study coordinator (Douglas Scott Denham) · 210-949-0122

Study leads

Douglas Scott Denham
Principal Investigator
5430 Fredericksburg Rd, Suite 200, San Antonio Texas 78229

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Safety, Tolerability, and Pharmacokinetics of ASCT-83 in Healthy Adults

Neuropathic Pain

Abroad (travel likely)RecruitingPHASE1

Saint Paul, United States

A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain

Diabetic Peripheral Neuropathic Pain

Abroad (travel likely)RecruitingPHASE2

Birmingham, United States · Phoenix, United States

SPENDD: Quantitative Sensory Testing and Analgesic Response for Painful Peripheral Neuropathy.

Painful Peripheral Neuropathy · Diabetic Peripheral Neuropathic Pain (DPN) · Chemotherapy Induced Peripheral Neuropathy (CIPN)

Abroad (travel likely)RecruitingPHASE2

Boston, United States · New York, United States

A Study of HRS-2129 in Patients With Diabetic Peripheral Neuropathic Pain

Diabetic Peripheral Neuropathic Pain

Abroad (travel likely)RecruitingPHASE1

Beijing, China · Chongqing, China